Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 1,445† | — | 915† | 716† | 701† |
| Net profit | 301 | 188 | 134† | 103† | 104† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| MARK SALDANHA | Executive Director | June 30, 2026 |
| SANDRA SALDANHA | Executive Director | June 30, 2026 |
| VARDDHMAN VIKRAMADITYA JAIN | Executive Director | June 30, 2026 |
| ABHINNA SUNDAR MOHANTY | Independent Director | June 30, 2026 |
| DIGANT MAHESH PARIKH | Independent Director | June 30, 2026 |
| SHAILAJA VARDHAN | Independent Director | June 30, 2026 |
| SRINIVAS MISHRA | Independent Director | June 30, 2026 |
| SUNNY SHARMA | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
